Showing results (591-600 of 663) with videos related to
Sort By:
Pageof 67
Swiss Medical Weekly|August 23, 2023
Association of chocolate consumption with neurological and cardiovascular outcomes in atrial fibrillation: data from two Swiss atrial fibrillation cohort studies (Swiss-AF and BEAT-AF)Annina Stauber, Andreas Müller, Nikki Rommers, et al.The Lancet. Global Health|July 8, 2021
Keeping an eye on eye care: monitoring progress towards effective coverageStuart Keel, Andreas Müller, Sandra Block, et al.BMJ Open Ophthalmology|August 22, 2020
Strengthening the integration of eye care into the health system: methodology for the development of the WHO package of eye care interventionsStuart Keel, Jennifer R Evans, Sandra Block, et al.GMS Zeitschrift Fur Medizinische Ausbildung|October 21, 2015
Development of a competency-based formative progress test with student-generated MCQs: Results from a multi-centre pilot studyStefan Wagener, Andreas Möltner, Sevgi Tımbıl, et al.Nature Methods|November 28, 2018
Content-aware image restoration: pushing the limits of fluorescence microscopyMartin Weigert, Uwe Schmidt, Tobias Boothe, et al.Heart Rhythm|August 23, 2024
Is electrical cardioversion independently associated with infarcts on brain magnetic resonance imaging or clinical outcomes in patients with atrial fibrillation?Annina Stauber, Andreas Müller, Nikki Rommers, et al.Heart Rhythm|May 18, 2024
Heart rate variability and stroke or systemic embolism in patients with atrial fibrillationPeter Hämmerle, Stefanie Aeschbacher, Vincent Schlageter, et al.Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|April 23, 2014
Continuous infusion of clonidine in ventilated newborns and infants: a randomized controlled trialChristoph Hünseler, Gunter Balling, Christoph Röhlig, et al.Plos One|January 27, 2016
Effects of Prednisolone on Disease Progression in Antiretroviral-Untreated HIV Infection: A 2-Year Randomized, Double-Blind Placebo-Controlled Clinical TrialChrista Kasang, Samuel Kalluvya, Charles Majinge, et al.Cell Reports. Medicine|December 19, 2025
Oxidized MIF is an Alzheimer's disease drug target relaying external risk factors to tau pathologyAndreas Müller-Schiffmann, Felix Torres, Anatoliy Kitaygorodskyy, et al.Pageof 67